Immunosurveillance, Immunodeficiencies and Lymphoproliferations

1. Front Matter

   Pages I-X

   PDF

2. Immunosurveillance, Immunodeficiency and Lymphoproliferations

   • Stephan H. Oertel, Hanno Riess

   Pages 1-8

3. Clinicopathologic Characteristics of Post-Transplant Lymphoproliferative Disorders

   • Michael A. Nalesnik

   Pages 9-18

4. Iatrogenic Lymphoproliferative Disorders in Non-Transplantation Settings

   • Onsi W. Kamel

   Pages 19-26

5. The Role of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8) in Lymphoproliferative Diseases

   • Ethel Cesarman

   Pages 27-37

6. Dendritic Cells for the Induction of EBV Immunity

   • Marion Subklewe

   Pages 38-43

7. NF-κB Inhibition in EBV-Transformed Lymphoblastoid Cell Lines

   • Ellen Cahir-McFarland, Elliott Kieff

   Pages 44-48

8. Epstein-Barr Viral Load as a Tool to Diagnose and Monitor Post-Transplant Lymphoproliferative Disease

   • Barbara C. Gärtner, Johannes Fischinger, Hansjörg Schäfer, Hermann Einsele, Klaus Roemer, Nikolaus Müller-Lantzsch

   Pages 49-54

9. The Role of Immunosuppression in Lymphoma

   • Jennifer Trofe, Joseph F. Buell, M. Roy First, Michael J. Hanaway, Tom M. Beebe, E. Steve Woodle

   Pages 55-66

10. Identification of Prognostic Factors in Post-Transplant Lymphoproliferative Disorders

    • Sylvain Choquet, Marie-France Mamzer Bruneel, Olivier Hermine, Raphaël Porcher, Stephanie Nguyen Quoc, Frédéric Davi et al.

    Pages 67-80

11. Methods and Objectives of a Large US Multicenter Case-Control Study of Post-Transplant Lymphoproliferative Disorder in Renal Transplant Patients

    • Donnie P. Funch, Joanne Brady, Hnin Hnin Ko, Nancy A. Dreyer, Alexander M. Walker

    Pages 81-88

12. Antiviral Treatment of Epstein-Barr Virus-Associated Lymphoproliferations

    • Stephan H. Oertel, Hanno Riess

    Pages 89-95

13. Low-Dose Chemotherapy for Children with Post-Transplant Lymphoproliferative Disease

    • Thomas G. Gross

    Pages 96-103

14. Engineered Antibody for Treating Lymphoma

    • G. T. Stevenson, V. A. Anderson, W. S. Leong

    Pages 104-112

15. Treatment of Post-Transplant Lymphomas with Anti-B-Cell Monoclonal Antibodies

    • Jeanne L. Garnier, G. Stevenson, N. Blanc-Brunat, J. L. Touraine, N. Milpied, V. Leblond et al.

    Pages 113-122

16. Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes for the Prevention and Treatment of EBV-Associated Post-Transplant Lymphomas

    • Zhensheng Liu, Barbara Savoldo, Helen Huls, Teresita Lopez, Adrian Gee, Jeffery Wilson et al.

    Pages 123-133

17. Non-Myeloablative Stem Cell Transplantation for Congenital Immunodeficiencies

    • H. B. Gaspar, P. Amrolia, A. Hassan, D. Webb, A. Jones, N. Sturt et al.

    Pages 134-142

18. Prognostic Factors in the Treatment of Human Immunodeficiency Virus-Associated Non-Hodgkin’s Lymphoma

    • David J. Straus

    Pages 143-148

19. Infusional CDE with Rituximab for the Treatment of Human Immunodeficiency Virus-Associated Non-Hodgkin’s Lymphoma: Preliminary Results of a Phase I/II Study

    • U. Tirelli, M. Spina, U. Jaeger, E. Nigra, P. L. Blanc, A. M. Liberati et al.

    Pages 149-153

20. Back Matter

    Pages 155-158

    PDF

This book covers lymphoproliferative disorders in patients with congenital or acquired immunodeficiencies. Acquired immunodeficiencies are caused by infections with the human immunodeficiency virus or arise following immunosuppressive therapy administered after organ transplantation or to treat connective tissue diseases such as rheumatoid arthritis. It was recently discovered that various diseases or therapeutic modalities that induce a state of immunosuppression may cause virally driven lymphoproliferations. This book summarizes for the first time this group of immunodeficiency-associated lymphoproliferations.

• AIDS lymphoma
• Epstein-Barr-Virus
• infections
• tissue
• transplantation

• Universitätsklinikum Charité-Campus Virchow Medizinische Klinik mit Schwerpunkt Hämatologie/Onkologie, Humboldt Universität zu Berlin, Berlin, Germany

  Stephan H. Oertel, Hanno Riess

Policies and ethics